Rezultaty - Hellings, Peter

Epithelial barriers in allergy and asthma od Hellings, Peter W., Steelant, Brecht

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Capsaicin for Rhinitis od Fokkens, Wytske, Hellings, Peter, Segboer, Christine

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Calu-3 epithelial cells exhibit different immune and epithelial barrier responses from freshly isolated primary nasal epithelial cells in vitro od Martens, Katleen, Hellings, Peter W., Steelant, Brecht

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Three-dimensional Morphing and Its Added Value in the Rhinoplasty Consult od Lekakis, Garyfalia, Hens, Greet, Claes, Peter, Hellings, Peter W.

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Long-term control in chronic rhinosinusitis after endoscopic sinus surgery od van der Veen, Julie, Timmermans, Marieke, Jorissen, Mark, Hellings, Peter

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Observational study: evaluating symptom control in allergic rhinitis at three years after starting immunotherapy od Droessaert, Valerie, Timmermans, Marieke, Ceuppens, Jan, Jorissen, Mark, Hellings, Peter

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Rhinoplasty from a rhinologist's perspective: Need for recognition of associated sinonasal conditions od Picavet, Valerie A., Grietens, Jente, Jorissen, Mark, Hellings, Peter W.

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch od Fokkens, Wytske, Hellings, Peter, Mullol, Joaquim, Munzel, Ullrich, Bachert, Claus

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Identification of gaps in the current allergic rhinitis guidelines and how these can be filled od Bousquet, Jean, Bachert, Claus, Mösges, Ralph, Fokkens, Wytske, Hellings, Peter

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment od Hoffmans, Ruth, Wagemakers, Alex, van Drunen, Cornelis, Hellings, Peter, Fokkens, Wytske

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies od Hellings, Peter, Bachert, Claus, Mösges, Ralph, Scadding, Glenis, Munzel, Ullrich, Fokkens, Wytske

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. od Bachert, Claus, Fokkens, Wytske, Hellings, Peter, Scadding, Glenis, Munzel, Ullrich, Mullol, Joaquim

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis od Scadding, Glenis, Bachert, Claus, Hellings, Peter, Fokkens, Wytske, Munzel, Ullrich, Mösges, Ralph

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

AB042. Allergy Working Group Update: the burden and management of rhinitis and rhinosinusitis in UK primary care od Fokkens, Wytske, Nibber, Anjan, Chisholm, Alison, Hellings, Peter, Skinner, Derek, Price, David

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Visual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden od Doulaptsi, Maria, Prokopakis, Emmanuel, Seys, Sven, Pugin, Benoit, Steelant, Brecht, Hellings, Peter

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

A TRiP Through the Roles of Transient Receptor Potential Cation Channels in Type 2 Upper Airway Inflammation od Backaert, Wout, Steelant, Brecht, Hellings, Peter W., Talavera, Karel, Van Gerven, Laura

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity od Scadding, Glenis, Price, David, Bousquet, Jean, Hellings, Peter, Fokkens, Wytske, Munzel, Ullrich, Bachert, Claus

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis od Hellings, Peter, Bachert, Claus, Bousquet, Jean, Scadding, Glenis, Fokkens, Wytske, Munzel, Ullrich, Price, David

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis od Price, David, Bousquet, Jean, Hellings, Peter, Scadding, Glenis, Fokkens, Wytske, Munzel, Ullrich, Bachert, Claus

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex od Price, David, Bousquet, Jean, Bachert, Claus, Fokkens, Wytske, Scadding, Glenis, Munzel, Ullrich, Hellings, Peter

Dokumenty pełnotekstowe Dokumenty pełnotekstowe